Sonnet CEO Pankaj Mohan dies; Raghu Rao named interim CEO

Sonnet BioTherapeutics Holdings, Inc.

CEO Pankaj Mohan passed away on March 31, 2025; board appointed Raghu Rao as interim CEO.
Stephen McAndrew, CBO, promoted to President and Chief Business Officer.
McAndrew's employment agreement: base salary $330,000, bonus up to 35%, severance terms.
Rao, 62, has background in federal contracts and board roles; no formal employment agreement yet.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Stephen McAndrew

President and Chief Business Officer

Sonnet BioTherapeutics Holdings, Inc.

Effective: 2025-03-31
Filed: April 1, 2025, 7:59 PM ET

promoted Stephen McAndrew, Ph.D., the Company’s current Chief Business Officer, to President and Chief Business Officer

Departed

Pankaj Mohan

President, Chief Executive Officer and Chairman of the Board

Sonnet BioTherapeutics Holdings, Inc.

Effective: 2025-03-31
Successor: Raghu Rao
Filed: April 1, 2025, 7:59 PM ET

As a result of the passing of Pankaj Mohan, President, Chief Executive Officer and Chairman of the Board of Directors (the “Board”) of Sonnet BioTherapeutics Holdings, Inc. (the “Company”), on March 31, 2025, the Board unanimously appointed Raghu Rao, 62, a current member of the Board, as interim Chief Executive Officer and promoted Stephen McAndrew, Ph.D., the Company’s current Chief Business Officer, to President and Chief Business Officer.

Appointed (interim)

Raghu Rao

interim Chief Executive Officer

Sonnet BioTherapeutics Holdings, Inc.

Effective: 2025-03-31
Filed: April 1, 2025, 7:59 PM ET

the Board unanimously appointed Raghu Rao, 62, a current member of the Board, as interim Chief Executive Officer

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Stephen McAndrew changed role as President and Chief Business Officer at Sonnet BioTherapeutics Holdings, Inc..

Action: promoted
Role: President and Chief Business Officer

Exact text from the filing

promoted Stephen McAndrew, Ph.D., the Company’s current Chief Business Officer, to President and Chief Business Officer

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Pankaj Mohan departed as President, Chief Executive Officer and Chairman of the Board at Sonnet BioTherapeutics Holdings, Inc..

Action: passed away
Role: President, Chief Executive Officer and Chairman of the Board

Exact text from the filing

As a result of the passing of Pankaj Mohan, President, Chief Executive Officer and Chairman of the Board of Directors (the “Board”) of Sonnet BioTherapeutics Holdings, Inc. (the “Company”), on March 31, 2025, the Board unanimously appointed Raghu Rao, 62, a current member of the Board, as interim Chief Executive Officer and promoted Stephen McAndrew, Ph.D., the Company’s current Chief Business Officer, to President and Chief Business Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Raghu Rao was appointed as interim Chief Executive Officer at Sonnet BioTherapeutics Holdings, Inc..

Action: appointed
Role: interim Chief Executive Officer

Exact text from the filing

the Board unanimously appointed Raghu Rao, 62, a current member of the Board, as interim Chief Executive Officer

View on SEC.gov

Source: SEC EDGAR

accession 0001641172-25-002119

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.